Astrelis
Dialysis facility · IL

DIALYSIS 142699

CCN 142699Latest FY 2020
Cost-report basis
HCRIS · as filed
Not audited by Astrelis
The read

A dialysis facility in IL. It ran an operating surplus of 8.2% in FY20 on $2.1M of operating revenue. It held 639 days of cash on hand (97th percentile among dialysis facilities on liquidity). Only a single comparable reporting year is available, so trend context is limited.

Operating margin · FY20
+8.2%
vs dialysis facilities42nd pctl of 7,741
Days cash on hand · FY20
639d
all sources
vs dialysis facilities97th pctl
Total operating revenue · FY20
$2.1M
vs dialysis facilities30th pctl
Total margin · incl. nonoperating · FY20
+8.2%
vs dialysis facilities42nd pctl

Where DIALYSIS 142699 sits among dialysis facilities

Operating margin · FY20 pool · n = 7,741 of 7,741 filed

Each point is one dialysis facility in the national distribution for this provider type, placed by operating margin. Facilities are not matched on size, case mix, or market — that is the matched-peer comparison in the paid benchmark. The dialysis facility median is +11.9%. Descriptive context only, not a ranking.

-20%-10%0%+10%+20%dialysis facility median +11.9%DIALYSIS 142699 +8.24%-20%0%+20%dialysis facility median +11.9%DIALYSIS 142699 +8.24%
One dialysis facilityDIALYSIS 142699dialysis facility median

The money

$ thousands · HCRIS cost-report basis · as filed, QA-gated

Ratios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio renders only when every input is reported in the filing; a year missing its core lines is not shown; a year whose balance sheet does not reconcile is labeled. Not audited by Astrelis.

Operating margin
+8.2% (FY20)
Operating income ÷ total operating revenue
HCRIS WS G-3
Total margin
+8.2% (FY20)
Net income ÷ total revenue incl. nonoperating
HCRIS WS G-3
Days cash on hand
639d (FY20)
Cash & investments ÷ daily operating expense
HCRIS WS G / G-3
Current ratio
1.46× (FY20)
Total current assets ÷ current liabilities
HCRIS WS G
Equity financing ratio
49% (FY20)
Total net assets ÷ total assets
HCRIS WS G
Days in net patient A/R
179d (FY20)
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
HCRIS WS G / G-3
$ in thousands
Line itemFY20
Patient revenue2,121
Total operating revenue2,121
Total operating expenses1,946
Operating income175
Operating margin %+8.3%
Net income175
Net income %+8.3%
1 of 3 years available for this statement.
HCRIS CMS-265 cost report · $ thousands · FY20–FY20 · operating revenue reflects net patient service revenue · FY20–21 may include COVID-era relief funding

How it operates

quality & operational context · CMS public reporting

The metrics this dialysis facility type is judged on: care quality, patient experience, and scale. Each is labeled by evidence class and public source; descriptive context only, never a ranking or adequacy claim.

Total treatments
7,243
Verified fact2020
HCRIS CMS-265
Cost per treatment ($)
268.62
Verified fact2020
HCRIS CMS-265
Net revenue per treatment ($)
292.76
Verified fact2020
HCRIS CMS-265

Trajectory

Cost-report basis · single reporting year
Operating margin
+8.2%FY20
Days cash on hand
639 daysFY20

The county this dialysis facility serves

Location, IL
Median household income
$81.8K
vs $82.1K US · $59.7K rural median
Poverty rate
13.3%
vs 12.5% US · 14.3% rural median
Uninsured
9.0%
vs 8.6% US · 8.4% rural median
Age 65+
15.5%
vs 16.8% US · 20.6% rural median
Fair or poor health
18.7%
self-reported, adults · CDC PLACES
Primary-care shortage
Designated
HRSA HPSA
Economic context: 7.8% of county personal income is Medicare/Medicaid medical benefits; 16.2% arrives as government transfers (BEA, 2022).
build aa21187 · 2026-07-28